Search results

Duplicate logging in distributed validation

Status: Open.

#241 In HannesStark/boltzgen;

· geraseva opened on Jun 10, 2026

Cyclic peptide design combined with motif scaffolding

Status: Open.

#240 In HannesStark/boltzgen;

· aoberstein opened on Jun 5, 2026

Small molecules are not recognized in protein design.

Status: Open.

#239 In HannesStark/boltzgen;

· William888666 opened on Jun 4, 2026

diversity calculation

Status: Open.

#238 In HannesStark/boltzgen;

· dhiraj82 opened on May 29, 2026

Bug: PDB parsing drops residues from secondary subchains in multi-chain entities

Status: Open.

#236 In HannesStark/boltzgen;

· Wodswos opened on May 27, 2026

Boltzgen hangs on DGX Spark

Status: Open.

#234 In HannesStark/boltzgen;

· yk-best opened on May 25, 2026

Unexpected peptide bond formation when using disulfide constraint with cyclic: false

Status: Open.

#233 In HannesStark/boltzgen;

· songxtracy-eng opened on May 25, 2026

redesigning experimentally validated binder

Status: Open.

#232 In HannesStark/boltzgen;

· dhiraj82 opened on May 22, 2026

How to design a dsRNA binder protein using Boltzgen?

Status: Open.

#231 In HannesStark/boltzgen;

· bee8617 opened on May 22, 2026

By default the nanobody-anything protocol computes peptide liabilities and not antibody ones

Status: Open.

#228 In HannesStark/boltzgen;

· nicolasboisseau opened on May 18, 2026

Calculating metrics for whole chain instead of the designed residues

Status: Open.

#227 In HannesStark/boltzgen;

· amin-sagar opened on May 16, 2026

How to keep fixed target chains in the input pose during nanobody CDRs design?

Status: Open.

#226 In HannesStark/boltzgen;

· IlJuma opened on May 14, 2026